
  
    
      
        Background_NNP
        Glaucoma_NNP is_VBZ a_DT leading_VBG cause_NN of_IN blindness_NN but_CC its_PRP$
        molecular_JJ etiology_NN is_VBZ poorly_RB understood_VBN ._. Glaucoma_NNP involves_VBZ
        retinal_JJ ganglion_NN cell_NN death_NN and_CC optic_JJ nerve_NN damage_NN that_WDT is_VBZ
        often_RB associated_VBN with_IN elevated_VBD intraocular_JJ pressure_NN (_( IOP_NNP )_) [_NN
        1_CD 2_CD 3_CD 4_CD 5_CD ]_NN ._.
        It_PRP is_VBZ becoming_VBG increasingly_RB clear_JJ that_IN many_JJ forms_NNS of_IN
        glaucoma_NN have_VBP a_DT genetic_JJ component_NN [_NN 6_CD 7_CD ]_NN ,_, and_CC much_JJ
        current_JJ research_NN is_VBZ focused_VBN on_IN identifying_VBG chromosomal_NN
        regions_NNS and_CC genes_NNS that_WDT contribute_VBP to_TO glaucoma_NN [_NN 8_CD 9_CD 10_CD ]_NN ._.
        Identifying_NNP such_JJ loci_NN allows_VBZ screening_NN for_IN individuals_NNS with_IN
        an_DT increased_VBN risk_NN of_IN developing_VBG glaucoma_NN [_NN 11_CD ]_NN ._.
        Identifying_NNP genes_NNS contributing_VBG to_TO elevated_VBD IOP_NNP and_CC glaucoma_NN
        is_VBZ only_RB the_DT first_JJ step_NN ,_, however_RB ,_, and_CC animal_NN models_NNS will_MD
        provide_VB systems_NNS for_IN subsequent_JJ hypothesis_NNS testing_NN and_CC
        experimental_JJ dissection_NN of_IN pathogenesis_NNS ._.
        Due_JJ to_TO conservation_NN in_IN mammalian_JJ physiology_NN and_CC the_DT
        powerful_JJ tools_NNS of_IN mouse_NN genetics_NNS ,_, mice_NNS are_VBP a_DT very_RB important_JJ
        experimental_JJ system_NN for_IN probing_VBG the_DT functions_NNS (_( both_DT in_IN
        health_NN and_CC disease_NN )_) of_IN many_JJ genes_NNS recently_RB identified_VBN by_IN
        sequencing_VBG the_DT human_JJ genome_NN [_NN 12_CD ]_NN ._. We_PRP have_VBP focused_VBN on_IN
        developing_VBG the_DT mouse_NN system_NN for_IN IOP_NNP and_CC glaucoma_NN studies_NNS [_NN
        13_CD 14_CD 15_CD 16_CD 17_CD 18_CD 19_CD ]_NN ._. Mice_NNS are_VBP expected_VBN to_TO be_VB extremely_RB
        helpful_JJ in_IN characterizing_VBG genes_NNS and_CC mechanisms_NNS that_WDT affect_VBP
        IOP_NNP or_CC the_DT susceptibility_NN of_IN the_DT optic_JJ nerve_NN and_CC retina_NN to_TO
        glaucomatous_JJ damage_NN [_NN 20_CD ]_NN ._.
        Very_RB little_JJ is_VBZ known_VBN about_IN the_DT magnitude_NN of_IN IOP_NNP of_IN
        various_JJ mouse_NN strains_NNS or_CC IOP_NNP fluctuation_NN in_IN mice_NNS with_IN time_NN
        or_CC other_JJ factors_NNS ._. Previously_RB ,_, we_PRP developed_VBD a_DT method_NN to_TO
        measure_VB IOP_NNP in_IN mice_NNS and_CC reported_VBD initial_JJ findings_NNS on_IN the_DT
        magnitude_NN of_IN mouse_NN IOP_NNP [_NN 13_CD ]_NN ._. The_DT procedure_NN involves_VBZ
        direct_JJ measurement_NN of_IN pressure_NN following_VBG cannulation_NN of_IN the_DT
        anterior_NN chamber_NN ._. The_DT initial_JJ experiments_NNS demonstrated_VBN that_IN
        in_IN our_PRP$ hands_NNS careful_JJ ocular_NN cannulation_NN has_VBZ a_DT very_RB minor_JJ
        effect_NN on_IN IOP_NNP (_( average_NN of_IN -_: 0_CD ._. 3_LS mmHg_NN ,_, mode_NN -_: 0_CD ._. 5_LS mmHg_NN )_) and_CC
        demonstrated_VBN significant_JJ differences_NNS in_IN intraocular_JJ
        pressure_NN levels_NNS between_IN four_CD mouse_NN strains_NNS ._. Here_RB ,_, we_PRP
        provide_VBP an_DT update_NN ,_, including_VBG an_DT extensive_JJ strain_NN survey_NN ,_,
        and_CC show_NN that_IN the_DT methodology_NN is_VBZ reliable_JJ and_CC produces_VBZ
        reproducible_JJ data_NNS over_IN extended_VBN periods_NNS of_IN time_NN ._.
      
      
        Results_NNS
        
          A_DT broad_JJ range_NN of_IN IOPs_NNP between_IN strains_NNS
          Figure_NN 1_CD shows_VBZ the_DT average_JJ IOP_NNP of_IN a_DT number_NN of_IN inbred_JJ
          mouse_NN strains_NNS that_WDT were_VBD housed_VBN in_IN the_DT same_JJ environmental_JJ
          conditions_NNS ._. There_EX is_VBZ a_DT wide_JJ range_NN of_IN IOP_NNP with_IN strain_NN
          BALB_NNP /_NN cJ_NN having_VBG one_CD of_IN the_DT lowest_JJS average_NN IOPs_NNP (_( 11_CD ._. 1_LS ±_NN 0_CD ._. 5_CD
          mmHg_NN )_) and_CC strain_NN CBA_NNP /_NN CaJ_NNP one_CD of_IN the_DT highest_JJS IOPs_NNP (_( 19_CD ._. 3_LS ±_NN
          0_CD ._. 3_CD mmHg_NN )_) ._. Significant_JJ differences_NNS exist_VBP among_IN various_JJ
          strains_NNS (_( P_NN <_NN 0_CD ._. 0001_CD for_IN all_DT groups_NNS ,_, ANOVA_NNP comparing_VBG
          strains_NNS within_IN each_DT sex_NN group_NN )_) ._.
          Clinical_NNP and_CC histological_JJ analysis_NN of_IN the_DT eyes_NNS of_IN all_DT
          studied_VBN strains_NNS (_( see_VB Table_NNP 1_LS )_) did_VBD not_RB identify_VB anatomic_JJ
          or_CC pathologic_JJ features_NNS that_WDT might_MD account_VB for_IN the_DT
          differences_NNS in_IN IOP_NNP ._. For_IN example_NN ,_, the_DT iridocorneal_NN angle_NN
          and_CC aqueous_JJ humor_NN drainage_NN structures_NNS are_VBP open_JJ to_TO the_DT
          anterior_NN chamber_NN and_CC have_VBP normal_JJ morphology_NN in_IN both_DT
          BALB_NNP /_NN cJ_NN and_CC CBA_NNP /_NN CaJ_NNP mice_NNS (_( Figure_NN 2_LS )_) ._. More_JJR than_IN 20_CD %_NN of_IN
          CBA_NNP /_NN CaJ_NNP mice_NNS had_VBD IOPs_NNP of_IN over_IN 21_CD mmHg_NN ,_, which_WDT increases_VBZ
          risk_VBP for_IN glaucoma_NN in_IN humans_NNS ._. We_PRP aged_VBN a_DT small_JJ group_NN of_IN
          these_DT mice_NNS (_( n_NN =_SYM 4_LS )_) to_TO 2_CD years_NNS and_CC histologically_RB analyzed_VBD
          their_PRP$ optic_JJ nerves_NNS and_CC retinas_NNS but_CC they_PRP did_VBD not_RB develop_VB
          glaucoma_NN ._.
        
        
          Strain_NNP differences_NNS are_VBP reproducible_JJ
          To_TO assess_VB the_DT consistency_NN of_IN IOP_NNP in_IN specific_JJ strains_NNS ,_,
          we_PRP measured_VBD IOP_NNP in_IN different_JJ cohorts_NNS of_IN each_DT strain_NN
          maintained_VBN under_IN similar_JJ conditions_NNS at_IN different_JJ times_NNS ._.
          We_PRP purposefully_RB included_VBD strains_NNS at_IN each_DT end_NN of_IN the_DT IOP_NNP
          spectrum_NN ,_, and_CC strain_NN C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP (_( B_NNP 6_CD )_) that_WDT is_VBZ commonly_RB used_VBN
          for_IN genetic_JJ experiments_NNS (_( Figure_NN 3_LS )_) ._. The_DT average_JJ IOP_NNP of_IN
          different_JJ cohorts_NNS of_IN strains_NNS CBA_NNP /_NN CaJ_NNP ,_, CBA_NNP /_NN CaHN_NNP (_( both_DT high_NN
          end_NN of_IN spectrum_NN )_) and_CC B_NNP 6_CD were_VBD consistent_JJ over_IN time_NN ._. This_DT
          was_VBD true_JJ of_IN most_JJS strains_NNS assessed_VBN on_IN multiple_JJ occasions_NNS ._.
          Average_NNP IOP_NNP for_IN age_NN matched_VBD mice_NNS of_IN the_DT same_JJ strain_NN
          assessed_VBN at_IN different_JJ times_NNS typically_RB differed_VBD by_IN no_RB more_JJR
          than_IN 1_CD ._. 5_CD mmHg_NN ,_, and_CC the_DT differences_NNS were_VBD usually_RB smaller_JJR ._.
          Strain_NNP 129_CD P_NN 3_CD /_NN J_NNP was_VBD the_DT most_RBS variable_JJ strain_NN with_IN the_DT
          average_JJ IOP_NNP fluctuating_VBG by_IN up_IN to_TO 2_CD ._. 5_CD mmHg_NN ._.
          Despite_IN the_DT general_JJ consistency_NN of_IN IOP_NNP ,_, the_DT average_JJ
          IOPs_NNP of_IN some_DT strains_NNS have_VBP changed_VBN in_IN a_DT reproducible_JJ
          manner_NN ._. The_DT IOPs_NNP of_IN BALB_NNP /_NN cJ_NN mice_NNS (_( low_JJ end_NN of_IN spectrum_NN )_)
          were_VBD very_RB similar_JJ for_IN the_DT past_JJ several_JJ years_NNS ,_, around_IN 11_CD
          mmHg_NN ._. Between_IN early_JJ 1996_CD and_CC 1997_CD ,_, however_RB ,_, the_DT IOP_NNP of_IN
          this_DT strain_NN did_VBD jump_NN from_IN approximately_RB 7_CD ._. 7_CD mmHg_NN to_TO
          approximately_RB 11_CD mmHg_NN (_( Figure_NN 3_LS )_) ._. During_IN this_DT period_NN ,_, the_DT
          room_NN in_IN which_WDT our_PRP$ animals_NNS were_VBD housed_VBN and_CC the_DT
          manufacturer_NN of_IN the_DT mouse_NN diet_NN were_VBD changed_VBN ._. Over_IN the_DT
          same_JJ period_NN ,_, the_DT IOP_NNP of_IN A_DT /_NN J_NNP also_RB increased_VBD dramatically_RB ,_,
          from_IN 9_CD ._. 4_CD ±_NN 0_CD ._. 5_CD mmHg_NN (_( n_NN =_SYM 11_CD )_) in_IN 1996_CD to_TO 14_CD ._. 2_LS ±_NN 0_CD ._. 4_CD mmHg_NN
          (_( n_NN =_SYM 19_CD )_) in_IN 1997_CD ._. The_DT increased_VBN IOP_NNP in_IN A_DT /_NN J_NNP also_RB was_VBD
          reproducible_JJ ,_, with_IN the_DT average_JJ IOP_NNP of_IN mice_NNS assessed_VBN in_IN
          the_DT year_NN 2000_CD being_VBG 14_CD ._. 5_LS ±_NN 0_CD ._. 4_CD mmHg_NN (_( n_NN =_SYM 16_CD )_) ._.
          Importantly_NNP ,_, the_DT IOPs_NNP of_IN strains_NNS B_NNP 6_CD and_CC C_NNP 3_CD H_NNP /_NN HeJ_NNP did_VBD not_RB
          change_VB during_IN this_DT time_NN (_( B_NNP 6_CD ,_, 12_CD ._. 3_LS ._. ±_NN 0_CD ._. 5_CD mmHg_NN in_IN 1996_CD and_CC
          12_CD ._. 4_LS ±_NN 0_CD ._. 3_CD mmHg_NN in_IN 1997_CD ,_, n_NN =_SYM 10_CD and_CC 14_CD ;_: C_NNP 3_CD H_NNP /_NN HeJ_NNP ,_, 13_CD ._. 7_CD ±_NN
          0_CD ._. 8_CD mmHg_NN in_IN 1996_CD and_CC 13_CD ._. 6_CD ±_NN 0_CD ._. 2_CD mmHg_NN in_IN 1997_CD ,_, n_NN =_SYM 9_CD and_CC
          19_CD )_) ._.
        
        
          Effect_NN of_IN age_NN on_IN IOP_NNP
          We_PRP focused_VBD on_IN the_DT commonly_RB used_VBN B_NNP 6_CD ,_, 129_CD P_NN 3_CD /_NN J_NNP and_CC
          C_NNP 3_CD H_NNP /_NN HeJ_NNP strains_NNS to_TO determine_VB the_DT effects_NNS of_IN age_NN on_IN IOP_NNP
          (_( Figure_NN 4_LS )_) ._. In_IN B_NNP 6_CD ,_, age_NN had_VBD a_DT significant_JJ effect_NN on_IN IOP_NNP (_( P_NN
          <_NN 0_CD ._. 001_CD )_) ._. IOP_NNP was_VBD slightly_RB decreased_VBN at_IN both_DT 12_CD months_NNS
          (_( 12_CD ._. 2_LS ±_NN 0_CD ._. 2_CD mmHg_NN )_) and_CC 19_CD months_NNS (_( 12_CD ._. 2_LS ±_NN 0_CD ._. 3_CD mmHg_NN )_)
          compared_VBN to_TO 3_CD months_NNS (_( 13_CD ._. 1_LS ±_NN 0_CD ._. 3_CD mmHg_NN )_) and_CC 7_CD months_NNS (_( 13_CD ._. 3_LS
          ±_NN 0_CD ._. 3_CD mmHg_NN )_) ._. Although_IN the_DT decrease_NN was_VBD of_IN a_DT similar_JJ level_NN
          to_TO the_DT variation_NN observed_VBD in_IN 3_CD month_NN old_JJ mice_NNS (_( see_VB Figure_NN
          3_LS )_) ,_, the_DT IOPs_NNP of_IN control_NN young_JJ mice_NNS (_( see_VB Methods_NNP )_) analyzed_VBD
          at_IN the_DT same_JJ times_NNS as_IN the_DT various_JJ B_NNP 6_CD age_NN groups_NNS did_VBD not_RB
          decrease_VB ._. For_IN example_NN ,_, control_NN mice_NNS analyzed_VBD at_IN the_DT same_JJ
          time_NN as_IN the_DT 3_CD month_NN ,_, 12_CD month_NN and_CC 18_CD month_NN B_NNP 6_CD age_NN groups_NNS
          had_VBD IOPs_NNP of_IN 13_CD ._. 0_CD ±_NN 0_CD ._. 2_CD mmHg_NN (_( n_NN =_SYM 14_CD )_) ,_, 13_CD ._. 3_LS ±_NN 0_CD ._. 2_CD mmHg_NN (_( n_NN
          =_SYM 14_CD )_) ,_, 13_CD ._. 7_CD ±_NN 0_CD ._. 4_CD mmHg_NN (_( n_NN =_SYM 12_CD )_) ,_, respectively_RB ._. IOP_NNP was_VBD
          even_RB lower_JJR in_IN the_DT 24_CD month_NN B_NNP 6_CD mice_NNS (_( 10_CD ._. 8_CD ±_NN 0_CD ._. 4_CD mmHg_NN )_) ,_, and_CC
          again_RB the_DT average_JJ IOP_NNP of_IN young_JJ controls_NNS measured_VBN at_IN the_DT
          same_JJ time_NN was_VBD not_RB changed_JJ (_( 13_CD ._. 5_LS ±_NN 0_CD ._. 2_CD ,_, n_NN =_SYM 12_CD )_) ._.
          In_IN strain_NN 129_CD P_NN 3_CD /_NN J_NNP ,_, IOP_NNP did_VBD not_RB differ_VB significantly_RB
          with_IN age_NN between_IN 3_CD and_CC 14_CD months_NNS but_CC was_VBD lower_JJR in_IN 18_CD
          month_NN old_JJ mice_NNS (_( P_NN <_NN 0_CD ._. 001_CD compared_VBN to_TO all_DT younger_JJR
          ages_NNS ,_, Figure_NN 4_LS )_) ._. Despite_IN a_DT 1_CD mmHg_NN dip_NN in_IN IOP_NNP at_IN 8_CD months_NNS ,_,
          there_EX were_VBD no_DT significant_JJ IOP_NNP differences_NNS between_IN C_NNP 3_CD H_NNP /_NN HeJ_NNP
          mice_NNS at_IN each_DT age_NN tested_VBN (_( P_NN =_SYM 0_CD ._. 2_CD for_IN age_NN )_) ._. Although_IN the_DT
          effect_NN of_IN age_NN has_VBZ not_RB been_VBN thoroughly_RB assessed_VBN in_IN other_JJ
          strains_NNS ,_, no_DT obvious_JJ age-related_JJ differences_NNS have_VBP been_VBN
          identified_VBN in_IN other_JJ strains_NNS analyzed_VBD at_IN multiple_JJ ages_NNS
          except_IN for_IN the_DT glaucomatous_JJ DBA_NNP /_NN 2_CD J_NNP and_CC AKXD-_NNP 28_CD /_NN Ty_NNP strains_NNS
          [_NN 14_CD 19_CD ]_NN ._.
        
        
          Effect_NN of_IN sex_NN on_IN IOP_NNP
          Although_IN we_PRP have_VBP not_RB rigorously_RB assessed_VBN the_DT effect_NN of_IN
          sex_NN on_IN IOP_NNP in_IN many_JJ strains_NNS ,_, sex_NN specific_JJ differences_NNS have_VBP
          not_RB been_VBN detected_VBN in_IN the_DT majority_NN of_IN strains_NNS for_IN which_WDT
          both_DT sexes_NNS have_VBP been_VBN analyzed_VBN ,_, and_CC have_VBP proven_VBN
          inconsistent_JJ even_RB within_IN an_DT individual_JJ strain_NN analyzed_VBD
          multiple_JJ times_NNS ._. Strains_NNP B_NNP 6_CD and_CC 129_CD P_NN 3_CD /_NN J_NNP have_VBP been_VBN
          extensively_RB evaluated_VBN at_IN multiple_JJ ages_NNS between_IN 3_CD and_CC 24_CD
          months_NNS of_IN age_NN ._. Sex_NN differences_NNS were_VBD always_RB absent_JJ in_IN
          strain_NN 129_CD P_NN 3_CD /_NN J_NNP and_CC typically_RB absent_JJ in_IN strain_NN B_NNP 6_CD ._. In_IN
          strain_NN B_NNP 6_CD ,_, however_RB ,_, males_NNS infrequently_RB had_VBD significantly_RB
          higher_JJR IOP_NNP than_IN females_NNS ._. For_IN example_NN ,_, in_IN one_CD experiment_NN ,_,
          B_NNP 6_CD males_NNS had_VBD an_DT average_JJ IOP_NNP of_IN 14_CD ._. 2_LS ±_NN 0_CD ._. 3_CD mmHg_NN (_( n_NN =_SYM 12_CD )_)
          whereas_IN the_DT average_JJ IOP_NNP of_IN females_NNS was_VBD 13_CD ._. 1_LS ±_NN 0_CD ._. 3_CD mmHg_NN (_( n_NN
          =_SYM 12_CD ,_, P_NN =_SYM 0_CD ._. 01_CD )_) ._. If_IN real_JJ ,_, this_DT sporadic_JJ sex_NN difference_NN
          was_VBD not_RB dependent_JJ on_IN age_NN ,_, sometimes_RB occurring_VBG in_IN a_DT group_NN
          of_IN B_NNP 6_CD mice_NNS at_IN a_DT particular_JJ age_NN and_CC sometimes_RB not_RB
          occurring_VBG in_IN a_DT separate_JJ group_NN of_IN the_DT same_JJ age_NN ._.
        
        
          Anesthesia_NNP protocol_NN avoids_VBZ IOP_NNP alteration_NN and_CC
          allows_VBZ detection_NN of_IN diurnal_NN differences_NNS
          All_DT IOPs_NNP were_VBD assessed_VBN using_VBG an_DT anesthetic_JJ regime_NN of_IN
          99_CD mg_NN /_NN kg_NN ketamine_NN and_CC 9_CD mg_NN /_NN kg_NN xylazine_NN (_( defined_VBN as_IN 1_CD X_NNP )_) ._.
          Initial_JJ experiments_NNS suggested_VBD that_IN an_DT almost_RB identical_JJ
          dose_NN (_( 100_CD mg_NN /_NN kg_NN ketamine_NN and_CC 9_CD mg_NN /_NN kg_NN xylazine_NN )_) of_IN
          anesthesia_NN had_VBD no_DT effect_NN on_IN IOP_NNP during_IN the_DT experimental_JJ
          period_NN with_IN IOP_NNP being_VBG measured_VBN as_RB soon_RB as_IN possible_JJ after_IN
          the_DT mouse_NN was_VBD unconscious_JJ ,_, typically_RB minutes_NNS ._. [_NN 13_CD ]_NN ._. To_TO
          further_VB assess_VB the_DT effects_NNS of_IN anesthesia_NN ,_, we_PRP measured_VBD IOP_NNP
          in_IN groups_NNS of_IN genetically_RB identical_JJ B_NNP 6_CD mice_NNS subjected_VBN to_TO
          different_JJ doses_NNS (_( 1_CD X_NNP ,_, 1_CD ._. 5_CD X_NNP and_CC 2_CD X_NNP )_) at_IN 5_CD and_CC 25_CD minutes_NNS
          after_IN administration_NN (_( Figure_NN 5_LS )_) ._. For_IN all_DT doses_NNS ,_, IOP_NNP
          decreased_VBN by_IN 25_CD minutes_NNS (_( P_NN =_SYM 0_CD ._. 005_CD for_IN time_NN )_) ._. The_DT greater_JJR
          the_DT dose_NN the_DT greater_JJR the_DT decrease_NN in_IN IOP_NNP ._. At_IN the_DT 5_CD minute_NN
          measurement_NN ,_, however_RB ,_, IOP_NNP was_VBD the_DT same_JJ using_VBG all_DT doses_NNS
          suggesting_VBG that_IN the_DT anesthetic_JJ effect_NN on_IN IOP_NNP had_VBD not_RB yet_RB
          occurred_VBD ._. To_TO identify_VB any_DT early_JJ window_NN when_WRB it_PRP may_MD be_VB
          possible_JJ to_TO assess_VB IOP_NNP without_IN an_DT obvious_JJ anesthetic_JJ
          effect_NN ,_, 195_CD mice_NNS of_IN strain_NN B_NNP 6_CD were_VBD anesthetized_JJ with_IN the_DT
          1_CD X_NNP dose_NN and_CC IOP_NNP was_VBD measured_VBN at_IN 1_CD minute_NN time_NN points_NNS
          between_IN 4_CD and_CC 12_CD minutes_NNS after_IN administration_NN (_( Figure_NN 5_LS )_) ._.
          The_DT mean_NN IOP_NNP of_IN groups_NNS analyzed_VBD at_IN each_DT time_NN point_NN did_VBD
          not_RB differ_VB (_( P_NN =_SYM 0_CD ._. 9_CD )_) indicating_VBG that_IN the_DT IOP_NNP depressing_JJ
          effect_NN of_IN anesthesia_NN occurs_VBZ later_RBR than_IN 12_CD minutes_NNS after_IN
          administration_NN ._. Similar_JJ results_NNS were_VBD obtained_VBN using_VBG 161_CD
          strain_NN 129_CD P_NN 3_CD /_NN J_NNP and_CC 145_CD strain_NN DBA_NNP /_NN 2_CD J_NNP mice_NNS with_IN the_DT 1_CD X_NNP
          dose_NN (_( 129_CD P_NN 3_CD /_NN J_NNP ,_, P_NN =_SYM 0_CD ._. 1_CD ;_: DBA_NNP /_NN 2_CD J_NNP ,_, P_NN =_SYM 0_CD ._. 2_LS )_) ._. In_IN support_NN of_IN a_DT
          later_JJ effect_NN of_IN anesthesia_NN (_( since_IN general_JJ anesthesia_NN is_VBZ
          reported_VBN to_TO mask_NN diurnal_NN variation_NN in_IN IOP_NNP [_NN 21_CD ]_NN )_) ,_, we_PRP
          identified_VBD increased_VBN IOP_NNP during_IN the_DT dark_JJ compared_VBN to_TO the_DT
          light_JJ period_NN of_IN the_DT day_NN in_IN several_JJ tested_VBN strains_NNS (_( Figure_NN
          6_CD )_) ._. In_IN these_DT experiments_NNS ,_, IOP_NNP measurements_NNS were_VBD made_VBN
          between_IN 5_CD and_CC 12_CD minutes_NNS after_IN administration_NN of_IN
          anesthesia_NN ._.
        
        
          Blood_NNP pressure_NN does_VBZ not_RB correlate_VBP with_IN IOP_NNP
          An_DT initial_JJ study_NN of_IN the_DT relationship_NN between_IN blood_NN
          pressure_NN and_CC IOP_NNP in_IN mice_NNS did_VBD not_RB detect_VB a_DT good_JJ
          correlation_NN (_( R_NN 2_CD =_SYM 0_CD ._. 1_CD ,_, Figure_NN 7_CD )_) ._.
        
        
          Myocalleles_NNP do_VBP not_RB associate_JJ with_IN the_DT magnitude_NN of_IN
          IOP_NNP
          Mutations_NNP in_IN the_DT myocilin_NN gene_NN (_( 
          MYOC_NNP )_) cause_VB human_JJ glaucoma_NN ._. To_TO
          determine_VB if_IN allelic_JJ variation_NN in_IN the_DT mouse_NN 
          Myoc_NNP gene_NN associated_VBN with_IN IOP_NNP in_IN
          mouse_NN strains_NNS ,_, we_PRP analyzed_VBD the_DT gene_NN in_IN an_DT assortment_NN of_IN
          strains_NNS with_IN different_JJ IOPs_NNP ._. Two_CD alleles_NNS were_VBD identified_VBN ._.
          One_CD of_IN these_DT alleles_NNS had_VBD a_DT 12_CD nucleotide_NN insertion_NN in_IN the_DT
          promoter_NN region_NN (_( ccagagcagggt_NN ,_, between_IN positions_NNS -_: 340_CD and_CC
          -_: 341_CD )_) compared_VBN to_TO the_DT previously_RB published_VBN sequence_NN and_CC
          is_VBZ called_VBN the_DT insertion_NN allele_NN ._. The_DT other_JJ allele_NN was_VBD
          identical_JJ to_TO the_DT published_VBN sequence_NN [_NN 22_CD ]_NN ._. The_DT
          insertion_NN allele_NN also_RB had_VBD a_DT previously_RB reported_VBN
          substitution_NN (_( A_DT to_TO G_NNP ,_, Thr_NNP 164_CD Ala_NNP )_) in_IN exon_NN 1_CD and_CC several_JJ
          other_JJ single_JJ base_NN changes_NNS in_IN the_DT promoter_NN region_NN [_NN 22_CD ]_NN ._.
          The_DT presence_NN or_CC absence_NN of_IN this_DT allele_NN does_VBZ not_RB associate_JJ
          with_IN IOP_NNP as_IN it_PRP is_VBZ present_JJ in_IN strains_NNS with_IN a_DT range_NN of_IN IOPs_NNP
          (_( Figure_NN 8_CD )_) ._.
        
        
          Genetic_JJ alterations_NNS and_CC IOP_NNP
          
            Y_NNP Chromosome_NNP
            The_DT Y_NNP chromosome_NN has_VBZ been_VBN implicated_VBN in_IN strain_NN
            specific_JJ blood_NN pressure_NN differences_NNS in_IN rats_NNS [_NN 23_CD 24_CD ]_NN ._.
            To_TO test_VB if_IN the_DT Y_NNP chromosome_NN of_IN strain_NN 129_CD /_NN Ola_NNP alters_NNS
            IOP_NNP in_IN relation_NN to_TO that_DT of_IN strain_NN B_NNP 6_CD ,_, we_PRP compared_VBD the_DT
            IOPs_NNP of_IN pure_JJ B_NNP 6_CD males_NNS and_CC consomic_JJ B_NNP 6_CD males_NNS that_WDT had_VBD
            the_DT 129_CD P_NN 2_CD /_NN Ola_NNP Y_NNP chromosome_NN (_( backcrossed_JJ for_IN 11_CD
            generations_NNS )_) ._. No_DT differences_NNS in_IN IOP_NNP were_VBD detected_VBN
            between_IN these_DT groups_NNS of_IN mice_NNS (_( Figure_NN 9_CD ,_, P_NN =_SYM 0_CD ._. 1_LS )_) ._.
          
          
            Car_NNP 2_CD
            To_TO test_VB if_IN deficiency_NN of_IN carbonic_JJ anhydrase_NN II_NNP leads_VBZ
            to_TO decreased_VBN IOP_NNP ,_, we_PRP analyzed_VBD mice_NNS of_IN a_DT B_NNP 6_CD background_NN
            that_WDT were_VBD genetically_RB similar_JJ but_CC with_IN normal_JJ or_CC mutant_JJ
            alleles_NNS of_IN the_DT 
            Car_NNP 2_CD gene_NN [_NN 25_CD 26_CD ]_NN ._. There_EX was_VBD
            no_DT difference_NN in_IN IOP_NNP between_IN normal_JJ and_CC mutant_JJ mice_NNS
            (_( Figure_NN 9_CD ,_, P_NN =_SYM 0_CD ._. 5_LS )_) ._.
          
          
            Lepr_NNP
            To_TO test_VB if_IN genetic_JJ perturbations_NNS that_WDT cause_VBP obesity_NN
            and_CC diabetes_NN can_MD alter_VB IOP_NNP ,_, we_PRP compared_VBD mice_NNS that_WDT were_VBD
            genetically_RB similar_JJ but_CC were_VBD either_CC homozygous_JJ or_CC
            heterozygous_JJ for_IN a_DT leptin_NN receptor_NN mutation_NN (_( 
            db_NN )_) that_IN results_NNS in_IN obesity_NN and_CC
            diabetes_NN before_IN 4_CD months_NNS of_IN age_NN on_IN the_DT C_NNP 57_CD BLKS_NNP /_NN J_NNP strain_NN
            background_NN used_VBD [_NN 27_CD ]_NN ._. IOP_NNP was_VBD modestly_RB but_CC
            significantly_RB elevated_VBD in_IN obese_NN ,_, diabetic_JJ homozygous_JJ
            mutants_NNS (_( 14_CD ._. 7_CD ±_NN 0_CD ._. 3_CD mmHg_NN )_) compared_VBN to_TO non-obese_JJ ,_,
            non-diabetic_JJ heterozygotes_NNS (_( 13_CD ._. 4_LS ±_NN 0_CD ._. 4_CD mmHg_NN ,_, P_NN <_NN
            0_CD ._. 01_CD ,_, Figure_NN 9_CD )_) ._.
          
          
            Tyr_NNP
            To_TO determine_VB if_IN albinism_NN alters_NNS IOP_NNP ,_, we_PRP analyzed_VBD B_NNP 6_CD
            mice_NNS that_WDT were_VBD either_DT pigmented_JJ or_CC albino_NN ._. The_DT albino_NN
            mice_NNS were_VBD homozygous_JJ and_CC coisogenic_JJ for_IN a_DT mutant_JJ allele_NN
            of_IN tyrosinase_NN (_( 
            Tyr_NNP 
            c_SYM -_: 2_CD 
            J_NNP )_) that_WDT arose_VBD on_IN the_DT otherwise_RB
            pigmented_JJ B_NNP 6_CD background_NN ._. In_IN 2_CD month_NN old_JJ mice_NNS ,_,
            homozygosity_NN for_IN 
            Tyr_NNP 
            c_SYM -_: 2_CD 
            J_NNP resulted_VBD in_IN increased_VBN IOP_NNP (_( 14_CD ._. 2_LS
            ±_NN 0_CD ._. 4_CD mmHg_NN )_) compared_VBN to_TO wild_JJ type_NN ,_, pigmented_JJ mice_NNS (_( 12_CD ._. 4_LS
            ±_NN 0_CD ._. 3_CD mmHg_NN ,_, P_NN <_NN 0_CD ._. 0001_CD )_) ._. The_DT same_JJ was_VBD true_JJ for_IN
            independent_JJ cohorts_NNS of_IN mice_NNS of_IN different_JJ ages_NNS that_WDT were_VBD
            analyzed_VBN at_IN different_JJ times_NNS (_( Figure_NN 10_CD A_DT )_) ._. In_IN contrast_NN
            to_TO pigmented_JJ B_NNP 6_CD mice_NNS (_( Figure_NN 6_CD )_) ,_, the_DT IOPs_NNP of_IN the_DT albino_NN
            B_NNP 6_CD mice_NNS were_VBD not_RB increased_VBN at_IN measurement_NN during_IN the_DT
            dark_JJ compared_VBN to_TO light_VB period_NN of_IN the_DT day_NN (_( P_NN =_SYM 0_CD ._. 6_CD ,_,
            Figure_NN 10_CD B_NNP )_) ._.
          
        
      
      
        Discussion_NNP
        
          IOP_NNP differences_NNS are_VBP reproducible_JJ and_CC amenable_JJ to_TO
          genetic_JJ analyses_NNS
          We_PRP report_VBP the_DT IOPs_NNP of_IN over_IN 30_CD genetically_RB different_JJ
          mouse_NN strains_NNS that_WDT were_VBD housed_VBN in_IN the_DT same_JJ environmental_JJ
          conditions_NNS ._. The_DT magnitude_NN of_IN IOP_NNP differences_NNS between_IN
          strains_NNS and_CC the_DT good_JJ reproducibility_NN of_IN readings_NNS over_IN
          time_NN will_MD allow_VB the_DT use_NN of_IN genetic_JJ approaches_NNS to_TO identify_VB
          genes_NNS that_WDT underlie_VB these_DT differences_NNS ._. Using_VBG our_PRP$ method_NN ,_,
          a_DT trained_VBN investigator_NN can_MD measure_VB the_DT IOPs_NNP of_IN 10_CD mice_NNS in_IN
          an_DT hour_NN ._. Thus_RB it_PRP is_VBZ feasible_JJ to_TO assess_VB sufficient_JJ numbers_NNS
          of_IN mice_NNS for_IN quantitative_JJ trait_NN locus_JJ (_( QTL_NNP )_) analysis_NN
          methods_NNS and_CC to_TO use_VB these_DT methods_NNS to_TO identify_VB chromosomal_NN
          regions_NNS contributing_VBG to_TO strain_VB differences_NNS in_IN IOP_NNP ._. The_DT
          strain_NN survey_NN we_PRP report_VBP provides_VBZ valuable_JJ information_NN for_IN
          designing_VBG these_DT experiments_NNS ._. The_DT throughput_NN and_CC
          reproducibility_NN also_RB is_VBZ sufficient_JJ for_IN mutagenesis_NNS
          screens_NNS [_NN 28_CD 29_CD 30_CD ]_NN ._. These_DT are_VBP important_JJ approaches_NNS as_IN
          they_PRP may_MD allow_VB the_DT association_NN of_IN genes_NNS with_IN IOP_NNP and_CC
          glaucoma_NN whose_WP$ currently_RB known_VBN functions_NNS do_VBP not_RB suggest_VB
          that_IN they_PRP affect_VBP aqueous_JJ humor_NN dynamics_NNS or_CC do_VBP not_RB
          immediately_RB identify_VB them_PRP as_IN likely_JJ glaucoma_NN
          candidates_NNS ._.
        
        
          No_DT effect_NN of_IN anesthetic_JJ protocol_NN on_IN IOP_NNP during_IN a_DT 12_CD
          minute_NN measurement_NN window_NN
          
            Similarities_NNP and_CC differences_NNS to_TO rat_VB
            studies_NNS
            Our_PRP$ results_NNS agree_VBP with_IN the_DT time_NN course_NN of_IN
            cardiovascular_JJ depression_NN caused_VBN by_IN intraperitoneal_NN
            administration_NN of_IN ketamine_NN and_CC xylazine_NN in_IN rats_NNS ._. In_IN
            that_DT study_NN ,_, anesthesia_NN had_VBD a_DT minor_JJ effect_NN on_IN blood_NN
            pressure_NN during_IN the_DT first_JJ 15_CD minutes_NNS following_VBG
            injection_NN but_CC a_DT strong_JJ hypotensive_JJ effect_NN between_IN 15_CD
            and_CC 30_CD minutes_NNS that_WDT continued_VBD for_IN more_JJR than_IN an_DT hour_NN [_NN
            35_CD ]_NN ._. In_IN contrast_NN ,_, intraperitoneally_RB administered_VBN
            ketamine_NN (_( 100_CD mg_NN /_NN kg_NN )_) was_VBD shown_VBN to_TO rapidly_RB decrease_VB IOP_NNP
            in_IN a_DT different_JJ rat_NN study_NN [_NN 36_CD ]_NN ._. IOP_NNP decreased_VBD
            significantly_RB between_IN a_DT conscious_JJ measurement_NN and_CC the_DT
            first_JJ possible_JJ measurement_NN under_IN anesthesia_NN (_( defined_VBN as_IN
            time_NN 0_CD )_) ._. IOP_NNP decreased_VBD further_RB by_IN the_DT next_JJ reading_NN (_( at_IN
            5_CD minutes_NNS )_) after_IN which_WDT it_PRP remained_VBD stable_JJ for_IN the_DT
            duration_NN of_IN the_DT experiment_NN (_( 20_CD minutes_NNS )_) [_NN 36_CD ]_NN ._. The_DT
            time_NN 0_CD measurement_NN in_IN that_DT study_NN was_VBD at_IN a_DT very_RB similar_JJ
            state_NN of_IN anesthesia_NN as_IN our_PRP$ 4_CD and_CC 5_CD minute_NN time_NN points_NNS
            (_( starting_VBG as_RB soon_RB as_IN possible_JJ and_CC within_IN 20_CD to_TO 60_CD
            seconds_NNS of_IN adequate_JJ anesthesia_NN )_) ,_, and_CC the_DT 5_CD minute_NN rat_NN
            time_NN point_NN was_VBD similar_JJ to_TO our_PRP$ 9_CD and_CC 10_CD minute_NN
            measurement_NN times_NNS ._. Thus_RB ,_, although_IN both_DT rat_NN and_CC mouse_NN
            studies_NNS show_VBP that_IN anesthesia_NN decreases_NNS IOP_NNP ,_, the_DT studies_NNS
            do_VBP not_RB agree_VB on_IN the_DT timing_NN of_IN the_DT effect_NN ._. The_DT IOP_NNP
            depression_NN occurred_VBD very_RB soon_RB after_IN anesthesia_NN in_IN the_DT
            rats_NNS but_CC was_VBD delayed_VBN in_IN the_DT mice_NNS ._.
          
        
        
          Environment_NNP may_MD influence_VB the_DT effect_NN of_IN
          anesthesia_NN
          Factors_NNP that_WDT may_MD influence_VB the_DT effect_NN of_IN anesthesia_NN
          include_VBP the_DT species_NNS ,_, strain_NN and_CC environment_NN used_VBN ._.
          Essentially_RB the_DT same_JJ dose_NN of_IN ketamine_NN and_CC route_NN of_IN
          administration_NN was_VBD used_VBN in_IN both_DT the_DT rat_NN and_CC mouse_NN IOP_NNP
          studies_NNS ._. In_IN mice_NNS ,_, the_DT strain_NN does_VBZ not_RB appear_VB to_TO be_VB
          important_JJ as_IN no_DT early_JJ effect_NN of_IN anesthesia_NN was_VBD present_JJ in_IN
          the_DT three_CD distantly_RB related_VBN laboratory_NN strains_NNS [_NN 37_CD ]_NN we_PRP
          studied_VBD in_IN detail_NN ,_, and_CC we_PRP have_VBP not_RB observed_VBN any_DT obvious_JJ
          effect_NN during_IN this_DT period_NN in_IN any_DT analyzed_VBN strain_NN ._.
          Environmental_JJ differences_NNS may_MD be_VB important_JJ ._. Cage_NNP
          cleanliness_NN ,_, changing_VBG frequency_NN and_CC housing_NN density_NN can_MD
          alter_VB drug_NN metabolism_NN and_CC the_DT effect_NN of_IN anesthesia_NN in_IN
          rats_NNS [_NN 38_CD 39_CD ]_NN ._. The_DT type_NN of_IN bedding_NN used_VBN also_RB may_MD be_VB
          important_JJ ._. We_PRP use_VBP wood_NN shavings_NNS for_IN bedding_NN and_CC wood_NN
          shavings_NNS expose_VBP the_DT mice_NNS to_TO terpenes_NNS ._. Terpene_NNP
          administration_NN or_CC environmental_JJ exposure_NN to_TO terpenes_NNS in_IN
          wood_NN shavings_NNS alters_NNS drug_NN resistance_NN and_CC decreases_VBZ the_DT
          effect_NN of_IN anesthetic_JJ agents_NNS in_IN both_DT rats_NNS and_CC mice_NNS [_NN 40_CD 41_CD
          42_CD 43_CD 44_CD 45_CD ]_NN ._.
        
        
          Risk_NN factors_NNS for_IN increased_VBN IOP_NNP
          
            Age_NNP
            Although_IN within_IN the_DT range_NN of_IN variability_NN observed_VBD in_IN
            young_JJ mice_NNS ,_, the_DT IOP_NNP of_IN B_NNP 6_CD mice_NNS modestly_RB decreased_VBD
            around_IN 1_CD year_NN of_IN age_NN ._. This_DT decrease_NN was_VBD statistically_RB
            significant_JJ compared_VBN to_TO young_JJ mice_NNS measured_VBN at_IN the_DT same_JJ
            time_NN ._. At_IN 2_CD years_NNS of_IN age_NN the_DT IOP_NNP of_IN B_NNP 6_CD mice_NNS had_VBD
            decreased_VBN further_RBR ,_, though_IN an_DT effect_NN of_IN anesthesia_NN in_IN
            these_DT very_RB old_JJ mice_NNS cannot_NN be_VB ruled_VBN out_IN [_NN 49_CD ]_NN ._. The_DT
            IOP_NNP of_IN 129_CD P_NN 3_CD /_NN J_NNP mice_NNS also_RB decreased_VBD with_IN age_NN but_CC only_RB at_IN
            the_DT oldest_JJS age_NN examined_VBD (_( 18_CD months_NNS )_) ._. Decreasing_NNP IOP_NNP
            correlates_NNS with_IN increasing_VBG age_NN in_IN the_DT human_JJ Japanese_JJ
            population_NN [_NN 50_CD 51_CD ]_NN ._. Further_RB studies_VBZ of_IN B_NNP 6_CD mice_NNS may_MD
            allow_VB experimental_JJ investigation_NN of_IN this_DT effect_NN ._.
            Additional_JJ studies_NNS may_MD also_RB identify_VB "_'' normal_JJ "_'' mouse_NN
            strains_NNS that_WDT develop_VBP increased_VBN IOP_NNP with_IN age_NN as_RB
            generally_RB occurs_VBZ in_IN Western_JJ populations_NNS [_NN 52_CD 53_CD ]_NN ._. We_PRP
            previously_RB demonstrated_VBD that_IN the_DT glaucomatous_JJ strains_NNS
            DBA_NNP /_NN 2_CD J_NNP and_CC AKXD-_NNP 28_CD /_NN Ty_NNP develop_VB elevated_VBD IOP_NNP with_IN age_NN [_NN
            14_CD 19_CD ]_NN ._.
          
          
            Gender_NNP
            In_IN the_DT examined_VBN strains_NNS ,_, we_PRP found_VBD no_DT consistent_JJ
            differences_NNS in_IN IOP_NNP between_IN males_NNS and_CC females_NNS ._. This_DT was_VBD
            true_JJ at_IN all_DT ages_NNS for_IN the_DT 3_CD strains_NNS that_WDT were_VBD aged_VBN to_TO 18_CD
            months_NNS or_CC older_JJR ._. This_DT is_VBZ in_IN agreement_NN with_IN a_DT number_NN of_IN
            human_JJ studies_NNS ,_, which_WDT show_VBP that_IN IOP_NNP is_VBZ equal_JJ between_IN the_DT
            sexes_NNS [_NN 52_CD 53_CD ]_NN ._. However_RB ,_, some_DT studies_NNS have_VBP found_VBN
            sex-specific_JJ differences_NNS (_( typically_RB with_IN higher_JJR IOP_NNP in_IN
            females_NNS and_CC the_DT magnitude_NN of_IN the_DT difference_NN increasing_VBG
            after_IN 40_CD years_NNS of_IN age_NN )_) [_NN 53_CD 54_CD ]_NN ._. Of_IN possible_JJ
            relevance_NN ,_, we_PRP previously_RB reported_VBD that_IN female_JJ mice_NNS of_IN
            strains_NNS DBA_NNP /_NN 2_CD J_NNP and_CC AKXD-_NNP 28_CD /_NN Ty_NNP develop_VB elevated_VBD IOP_NNP at_IN
            an_DT earlier_JJR age_NN than_IN males_NNS [_NN 14_CD 19_CD ]_NN ._.
          
          
            Blood_NNP pressure_NN
            Some_DT but_CC not_RB all_DT human_JJ studies_NNS have_VBP reported_VBN a_DT
            positive_JJ association_NN between_IN IOP_NNP and_CC blood_NN pressure_NN [_NN
            48_CD 52_CD ]_NN ._. Our_PRP$ comparison_NN of_IN the_DT relationship_NN between_IN
            blood_NN pressure_NN and_CC IOP_NNP in_IN young_JJ ,_, adult_JJ female_JJ mice_NNS of_IN
            different_JJ mouse_NN strains_NNS ,_, whose_WP$ blood_NN pressures_NNS differed_VBD
            up_IN to_TO 36_CD mmHg_NN ,_, did_VBD not_RB reveal_VB a_DT positive_JJ correlation_NN ._.
            Further_RB studies_VBZ are_VBP needed_VBN to_TO determine_VB if_IN blood_NN
            pressure_NN correlates_NNS with_IN IOP_NNP in_IN males_NNS ,_, and_CC to_TO determine_VB
            the_DT relationship_NN between_IN blood_NN pressure_NN and_CC IOP_NNP in_IN
            various_JJ mouse_NN strains_NNS with_IN age_NN ._.
          
          
            Obesity_NNP and_CC diabetes_NN
            Obesity_NNP or_CC higher_JJR body_NN mass_NN index_NN have_VBP been_VBN
            implicated_VBN by_IN some_DT but_CC not_RB other_JJ studies_NNS as_IN risk_NN
            factors_NNS for_IN increased_VBN IOP_NNP and_CC glaucoma_NN [_NN 51_CD 55_CD 56_CD 57_CD ]_NN
            ._. Similarly_RB ,_, diabetes_NN or_CC the_DT combination_NN of_IN diabetes_NN
            and_CC obesity_NN have_VBP been_VBN variably_RB associated_VBN with_IN elevated_VBD
            IOP_NNP and_CC glaucoma_NN [_NN 46_CD 52_CD 58_CD 59_CD 60_CD 61_CD 62_CD ]_NN ._. To_TO test_VB if_IN
            genetic_JJ perturbations_NNS that_WDT cause_VBP obesity_NN and_CC diabetes_NN
            can_MD alter_VB IOP_NNP ,_, we_PRP compared_VBD groups_NNS of_IN mice_NNS that_WDT were_VBD
            genetically_RB similar_JJ except_IN that_IN they_PRP were_VBD either_CC
            homozygous_JJ or_CC heterozygous_JJ for_IN a_DT leptin_NN receptor_NN
            mutation_NN (_( 
            db_NN )_) that_IN results_NNS in_IN early_JJ onset_NN
            obesity_NN and_CC diabetes_NN ._. The_DT obese_NN ,_, diabetic_JJ mice_NNS had_VBD
            higher_JJR IOPs_NNP than_IN their_PRP$ lean_JJ ,_, non-diabetic_JJ littermates_NNS ._.
            Thus_RB ,_, epidemiological_JJ associations_NNS between_IN increased_VBN
            IOP_NNP and_CC obesity_NN or_CC diabetes_NN are_VBP supported_VBN by_IN this_DT work_NN
            and_CC appear_VB to_TO be_VB functionally_RB relevant_JJ ._. Further_RB
            experiments_NNS with_IN obese_NN non-diabetic_JJ or_CC diabetic_JJ
            non-obese_JJ mice_NNS will_MD help_VB to_TO characterize_VB the_DT separate_JJ
            effects_NNS of_IN these_DT risk_NN factors_NNS ._.
          
        
        
          IOP_NNP is_VBZ increased_VBN during_IN the_DT dark_JJ period_NN of_IN the_DT
          day_NN
          Diurnal_NNP variation_NN in_IN IOP_NNP is_VBZ common_JJ in_IN humans_NNS and_CC
          laboratory_NN animals_NNS [_NN 53_CD ]_NN ._. The_DT molecular_JJ mechanisms_NNS
          underlying_VBG the_DT diurnal_NN rhythm_NN are_VBP not_RB defined_VBN but_CC
          increased_VBN aqueous_JJ humor_NN production_NN or_CC flow_NN occurs_VBZ during_IN
          the_DT period_NN of_IN increased_VBN IOP_NNP in_IN both_DT rabbits_NNS and_CC humans_NNS [_NN
          63_CD 64_CD 65_CD ]_NN ._. Small_JJ changes_NNS in_IN the_DT resistance_NN to_TO aqueous_JJ
          humor_NN drainage_NN may_MD also_RB contribute_VB to_TO diurnal_NN differences_NNS
          in_IN IOP_NNP [_NN 66_CD 67_CD ]_NN ._. We_PRP first_RB suspected_VBN IOP_NNP changes_NNS with_IN
          time_NN of_IN day_NN when_WRB the_DT IOP_NNP of_IN a_DT group_NN of_IN B_NNP 6_CD mice_NNS measured_VBN
          in_IN the_DT hour_NN prior_RB to_TO onset_NN of_IN the_DT dark_JJ period_NN appeared_VBD to_TO
          be_VB higher_JJR than_IN at_IN other_JJ times_NNS of_IN day_NN ._. Previously_RB ,_, a_DT rise_NN
          of_IN IOP_NNP was_VBD reported_VBN to_TO occur_VB before_IN onset_NN of_IN the_DT dark_JJ
          period_NN in_IN rats_NNS [_NN 21_CD ]_NN ,_, and_CC rats_NNS and_CC rabbits_NNS were_VBD shown_VBN
          to_TO have_VB higher_JJR IOP_NNP during_IN the_DT dark_JJ period_NN compared_VBN to_TO the_DT
          light_JJ period_NN [_NN 21_CD 68_CD 69_CD ]_NN ._. Thus_RB ,_, we_PRP compared_VBD the_DT IOPs_NNP of_IN
          mice_NNS at_IN different_JJ times_NNS of_IN day_NN and_CC identified_VBN several_JJ
          strains_NNS with_IN significantly_RB higher_JJR IOP_NNP during_IN the_DT dark_JJ
          compared_VBN to_TO the_DT light_JJ period_NN ._. The_DT magnitude_NN of_IN the_DT
          difference_NN varies_VBZ with_IN strain_NN ,_, and_CC was_VBD greatest_JJS in_IN SWR_NNP /_NN J_NNP ._.
          The_DT IOP_NNP increase_NN in_IN the_DT dark_NN is_VBZ not_RB dependent_JJ on_IN
          functional_JJ rod_NN and_CC cone_NN photoreceptors_NNS since_IN these_DT cells_NNS
          degenerate_VB in_IN SWR_NNP /_NN J_NNP mice_NNS due_JJ to_TO homozygosity_NN for_IN the_DT 
          Pde_NNP 6_CD b_SYM 
          rd_NN 1_CD mutation_NN ._. In_IN agreement_NN with_IN
          this_DT finding_NN ,_, circadian_NN regulation_NN of_IN wheel_NN running_VBG by_IN
          light_NN was_VBD previously_RB reported_VBN in_IN mice_NNS lacking_VBG rods_NNS and_CC
          cones_NNS [_NN 70_CD ]_NN ._. Interestingly_RB ,_, the_DT IOP_NNP of_IN strain_NN CBA_NNP /_NN CaJ_NNP ,_,
          which_WDT has_VBZ one_CD of_IN the_DT highest_JJS daytime_JJ IOPs_NNP does_VBZ not_RB appear_VB
          to_TO increase_VB in_IN the_DT dark_NN ._. Further_RB more_RBR detailed_JJ studies_NNS
          are_VBP needed_VBN to_TO define_VB the_DT characteristics_NNS of_IN the_DT diurnal_NN
          rhythm_NN of_IN intraocular_JJ pressure_NN in_IN mice_NNS ,_, and_CC to_TO determine_VB
          whether_IN it_PRP is_VBZ lacking_VBG or_CC has_VBZ a_DT different_JJ timing_NN in_IN strain_NN
          CBA_NNP /_NN CaJ_NNP ._. Analysis_NNP of_IN these_DT mouse_NN strains_NNS may_MD increase_VB
          understanding_VBG of_IN the_DT molecular_JJ mechanisms_NNS controlling_VBG
          diurnal_NN rhythms_NNS of_IN IOP_NNP and_CC that_DT may_MD be_VB relevant_JJ to_TO
          glaucoma_NN ._.
        
        
          Car_NNP 2_CD deficiency_NN does_VBZ not_RB alter_VB IOP_NNP
          Bicarbonate_NNP formation_NN is_VBZ important_JJ for_IN aqueous_JJ humor_NN
          secretion_NN from_IN the_DT ciliary_JJ processes_VBZ and_CC carbonic_JJ
          anhydrase_NN (_( CA_NNP )_) facilitates_NNS this_DT secretion_NN ._. There_EX are_VBP
          multiple_JJ forms_NNS of_IN CA_NNP and_CC the_DT CAII_NNP isoform_NN is_VBZ reported_VBN to_TO
          be_VB the_DT predominant_NN form_NN in_IN the_DT ciliary_JJ processes_VBZ [_NN 71_CD 72_CD
          ]_NN ._. Our_PRP$ experiments_NNS show_VBP that_IN a_DT genetic_JJ deficiency_NN of_IN
          CAII_NNP in_IN mice_NNS homozygous_JJ for_IN a_DT mutation_NN in_IN the_DT 
          Car_NNP 2_CD gene_NN does_VBZ not_RB alter_VB IOP_NNP ._. CAIV_NNP
          activity_NN was_VBD recently_RB demonstrated_VBN in_IN the_DT ciliary_JJ
          processes_VBZ [_NN 73_CD ]_NN and_CC so_RB our_PRP$ data_NNS may_MD support_VB a_DT more_RBR
          substantial_JJ role_NN for_IN CAIV_NNP compared_VBD to_TO CAII_NNP in_IN aqueous_JJ
          humor_NN secretion_NN ._. It_PRP also_RB is_VBZ possible_JJ that_IN CAII_NNP
          substantially_RB contributes_VBZ to_TO aqueous_JJ humor_NN secretion_NN but_CC
          that_IN functional_JJ mouse_NN CAIV_NNP is_VBZ sufficient_JJ to_TO prevent_VB an_DT
          effect_NN of_IN CAII_NNP deficiency_NN on_IN IOP_NNP in_IN 
          Car_NNP 2_CD mutant_JJ mice_NNS ._. In_IN support_NN of_IN a_DT
          role_NN for_IN both_DT enzymes_NNS ,_, a_DT greater_JJR than_IN 90_CD %_NN inhibition_NN of_IN
          CA_NNP is_VBZ required_VBN for_IN significant_JJ reduction_NN of_IN aqueous_JJ
          secretion_NN [_NN 71_CD 72_CD ]_NN ._.
        
        
          Tyrosinase_NNP deficiency_NN results_NNS in_IN increased_VBN
          IOP_NNP
          Tyrosinase_NNP is_VBZ the_DT first_JJ enzyme_NN of_IN the_DT pigment_NN
          production_NN pathway_NN ._. Tyrosinase_NNP deficiency_NN causes_NNS albinism_NN
          and_CC has_VBZ various_JJ ocular_NN consequences_NNS ._. These_DT include_VBP
          alteration_NN of_IN the_DT number_NN of_IN ipsilaterally_RB projecting_VBG
          retinal_JJ axons_NNS and_CC substantially_RB increased_VBN light_JJ
          penetration_NN past_JJ the_DT iris_NNS [_NN 74_CD ]_NN ._. It_PRP is_VBZ not_RB known_VBN if_IN
          these_DT abnormalities_NNS affect_VBP mammalian_JJ IOP_NNP ._. Here_RB ,_, we_PRP show_VBP
          increased_VBN IOP_NNP in_IN mice_NNS lacking_VBG tyrosinase_NN activity_NN
          compared_VBN to_TO otherwise_RB genetically_RB identical_JJ pigmented_JJ B_NNP 6_CD
          mice_NNS ._. Additionally_RB ,_, IOP_NNP differences_NNS between_IN the_DT light_JJ and_CC
          dark_JJ period_NN of_IN the_DT day_NN were_VBD detected_VBN in_IN the_DT pigmented_JJ but_CC
          not_RB the_DT albino_NN B_NNP 6_CD mice_NNS ._. Thus_RB ,_, albinism_NN can_MD affect_VB the_DT
          diurnal_NN pattern_NN of_IN IOP_NNP changes_NNS ._. In_IN agreement_NN with_IN this_DT
          result_NN ,_, mice_NNS with_IN albino_NN eyes_NNS that_WDT are_VBP homozygous_JJ for_IN
          tyrosinase_NN or_CC pink_JJ eye_NN dilution_NN mutations_NNS have_VBP altered_VBN
          diurnal_NN rhythms_NNS compared_VBN to_TO pigmented_JJ mice_NNS [_NN 75_CD ]_NN ._.
          Albinism_NNP by_IN itself_PRP is_VBZ either_CC not_RB sufficient_JJ to_TO alter_VB the_DT
          diurnal_NN rhythm_NN of_IN IOP_NNP or_CC alters_NNS it_PRP in_IN different_JJ ways_NNS
          depending_VBG upon_IN genetic_JJ background_NN ,_, however_RB ,_, since_IN the_DT
          albino_NN strains_NNS BALB_NNP /_NN cByJ_NN and_CC SWR_NNP /_NN J_NNP had_VBD increased_VBN IOP_NNP
          during_IN the_DT dark_NN ._. Diurnal_NNP rhythms_NNS are_VBP known_VBN to_TO depend_VB on_IN
          visual_JJ pathways_NNS and_CC to_TO respond_VB to_TO light_VB intensity_NN ._.
          Exposing_NNP rats_NNS to_TO 24_CD hours_NNS of_IN low_JJ light_JJ abrogates_NNS the_DT
          diurnal_NN fluctuation_NN of_IN IOP_NNP and_CC results_NNS in_IN constantly_RB
          elevated_VBD IOP_NNP [_NN 36_CD ]_NN ._. Further_RB experiments_NNS will_MD determine_VB
          the_DT nature_NN of_IN the_DT diurnal_NN rhythm_NN of_IN IOP_NNP in_IN the_DT albino_NN B_NNP 6_CD
          mice_NNS and_CC if_IN its_PRP$ alteration_NN or_CC other_JJ mechanisms_NNS result_VBP in_IN
          IOP_NNP elevation_NN ._.
        
      
      
        Conclusions_NNP
        A_DT broad_JJ range_NN of_IN reproducible_JJ IOP_NNP differences_NNS exists_VBZ
        between_IN inbred_JJ mouse_NN strains_NNS and_CC a_DT diurnal_NN rhythm_NN of_IN IOP_NNP
        exists_VBZ in_IN different_JJ strains_NNS ._. Various_JJ factors_NNS have_VBP been_VBN
        variably_RB associated_VBN with_IN risk_NN for_IN increased_VBN IOP_NNP in_IN humans_NNS ._.
        Genetically_NNP uniform_NN ,_, mice_NNS can_MD be_VB used_VBN to_TO study_VB the_DT effects_NNS
        of_IN these_DT risk_NN factors_NNS on_IN IOP_NNP ._. In_IN trained_VBN hands_NNS ,_, our_PRP$
        measurement_NN procedure_NN is_VBZ reliable_JJ ,_, accurate_JJ and_CC rapid_JJ
        enough_RB to_TO allow_VB large_JJ scale_NN genetic_JJ studies_NNS of_IN factors_NNS
        determining_VBG IOP_NNP ._. Mice_NNS have_VBP great_JJ potential_NN for_IN helping_VBG to_TO
        characterize_VB the_DT molecular_JJ mechanisms_NNS affecting_VBG IOP_NNP ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Animal_NNP husbandry_NN
          All_DT experiments_NNS were_VBD performed_VBN in_IN compliance_NN with_IN the_DT
          ARVO_NNP statement_NN for_IN use_NN of_IN animals_NNS in_IN ophthalmic_JJ and_CC
          vision_NN research_NN ._. All_DT mice_NNS were_VBD bred_VBN and_CC maintained_VBN at_IN The_DT
          Jackson_NNP Laboratory_NNP ._. Mice_NNS were_VBD housed_VBN in_IN cages_NNS containing_VBG
          white_JJ pine_VBP bedding_NN and_CC covered_VBN with_IN polyester_NN filters_NNS ._.
          For_IN most_JJS experiments_NNS ,_, the_DT mice_NNS were_VBD fed_VBN NIH_NNP 31_CD (_( 6_CD %_NN fat_JJ )_)
          chow_NN 
          ad_NN libitum_NN ,_, and_CC their_PRP$ water_NN was_VBD
          acidified_VBN to_TO pH_NN 2_CD ._. 8_CD to_TO 3_CD ._. 2_CD ._. B_NNP 6_CD mice_NNS develop_VBP diet_NN induced_VBD
          diabetes_NN when_WRB maintained_VBN on_IN a_DT high_JJ fat_JJ diet_NN [_NN 76_CD ]_NN ._. To_TO
          ensure_VB that_IN we_PRP were_VBD analyzing_VBG the_DT effect_NN of_IN age_NN and_CC not_RB
          diabetes_NN ,_, the_DT B_NNP 6_CD mice_NNS in_IN the_DT aging_VBG experiment_NN were_VBD fed_VBN
          NIH_NNP 31_CD (_( 4_CD %_NN fat_JJ )_) chow_NN ._. We_PRP have_VBP found_VBN no_DT differences_NNS in_IN IOP_NNP
          between_IN B_NNP 6_CD mice_NNS housed_VBN on_IN the_DT 4_CD %_NN fat_JJ and_CC 6_CD %_NN fat_JJ versions_NNS
          of_IN this_DT otherwise_RB identical_JJ diet_NN ._. The_DT mice_NNS were_VBD group_NN
          housed_VBN and_CC the_DT cages_NNS were_VBD changed_VBN one_CD time_NN per_IN week_NN ._. If_IN
          any_DT cage_NN appeared_VBD soiled_VBD between_IN scheduled_VBN changes_NNS ,_, the_DT
          mice_NNS were_VBD placed_VBN in_IN a_DT clean_JJ cage_NN ._. The_DT environment_NN was_VBD
          kept_VBN at_IN 21_CD °_NN C_NNP with_IN a_DT 14_CD hour_NN light_JJ :_: 10_CD hour_NN dark_JJ cycle_NN ._.
          The_DT colony_NN was_VBD monitored_VBN for_IN specific_JJ pathogens_NNS by_IN The_DT
          Jackson_NNP Laboratory_NNP 's_POS routine_JJ surveillance_NN program_NN (_( see_VB
          http_NN :_: /_NN /_NN www_NN ._. jax_NN ._. orgfor_NN specific_JJ pathogens_NNS )_) ._.
        
        
          Intraocular_NNP pressure_NN
          Intraocular_NNP pressures_NNS were_VBD measured_VBN as_IN described_VBN
          elsewhere_RB [_NN 13_CD 77_CD ]_NN ._. The_DT mice_NNS were_VBD typically_RB
          acclimatized_JJ to_TO the_DT procedure_NN room_NN for_IN at_IN least_JJS 2_CD weeks_NNS
          prior_RB to_TO measurement_NN ,_, but_CC sometimes_RB between_IN 1_CD and_CC 2_CD
          weeks_NNS ._. Although_IN it_PRP was_VBD not_RB possible_JJ to_TO include_VB all_DT
          strains_NNS in_IN each_DT measurement_NN period_NN ,_, mice_NNS of_IN different_JJ
          strains_NNS were_VBD intermixed_VBD ._. As_IN demonstrated_VBN here_RB ,_, the_DT IOPs_NNP
          of_IN C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP are_VBP very_RB consistent_JJ over_IN time_NN and_CC so_IN these_DT
          animals_NNS were_VBD interspersed_VBN with_IN experimental_JJ mice_NNS during_IN
          all_DT experiments_NNS to_TO ensure_VB that_DT calibration_NN had_VBD not_RB
          drifted_VBD and_CC that_IN the_DT system_NN was_VBD functioning_VBG optimally_RB ._.
          Whenever_WRB possible_JJ ,_, the_DT investigator_NN measuring_VBG IOP_NNP did_VBD not_RB
          know_VB the_DT genotypes_NNS of_IN the_DT animals_NNS ._. It_PRP was_VBD not_RB possible_JJ to_TO
          analyze_VB all_DT age_NN groups_NNS of_IN each_DT strain_NN at_IN the_DT same_JJ time_NN in_IN
          the_DT aging_VBG experiments_NNS ._. Therefore_RB ,_, to_TO control_VB for_IN
          potential_JJ IOP_NNP changes_NNS due_JJ to_TO measurement_NN time_NN and_CC not_RB
          age_NN ,_, approximately_RB 3_CD month_NN old_JJ B_NNP 6_CD mice_NNS were_VBD assessed_VBN at_IN
          the_DT same_JJ time_NN as_IN each_DT age_NN group_NN ._. All_DT dark_JJ period_NN
          measurements_NNS were_VBD made_VBN between_IN 1_CD and_CC 3_CD hours_NNS after_IN the_DT
          lights_NNS turned_VBD off_RP ._. The_DT room_NN was_VBD equipped_VBN with_IN dim_NN red_JJ
          lights_NNS and_CC mice_NNS were_VBD protected_VBN from_IN all_DT light_JJ exposure_NN
          during_IN set_VBN up_RP ._. Each_DT mouse_NN was_VBD briefly_NN exposed_VBN to_TO the_DT red_JJ
          light_JJ when_WRB the_DT anesthetic_JJ agents_NNS were_VBD administered_VBN ._. When_WRB
          adequate_JJ anesthesia_NN was_VBD achieved_VBN (_( after_IN 3_CD to_TO 4_CD minutes_NNS )_) ,_,
          the_DT mouse_NN was_VBD placed_VBN on_IN the_DT measurement_NN platform_NN and_CC the_DT
          white_JJ light_NN of_IN the_DT microscope_NN was_VBD turned_VBN on_IN (_( for_IN
          approximately_RB 1_CD and_CC a_DT half_NN minutes_NNS )_) to_TO allow_VB ocular_NN
          cannulation_NN ,_, IOP_NNP measurement_NN and_CC post-measurement_JJ tests_NNS [_NN
          13_CD ]_NN that_DT guard_NN against_IN artifactual_NN data_NNS ._. The_DT white_JJ light_NN
          was_VBD used_VBN at_IN very_RB low_JJ intensity_NN and_CC was_VBD dim_NN but_CC we_PRP cannot_NN
          rule_NN out_RP the_DT possibility_NN that_IN this_DT brief_JJ exposure_NN altered_VBD
          the_DT IOP_NNP ._. All_DT other_JJ mice_NNS were_VBD protected_VBN from_IN light_JJ
          exposure_NN throughout_IN the_DT time_NN an_DT individual_JJ mouse_NN was_VBD
          analyzed_VBN ._.
        
        
          Blood_NNP pressure_NN
          The_DT blood_NN pressures_NNS of_IN conscious_JJ mice_NNS of_IN each_DT strain_NN
          (_( 6_CD to_TO 12_CD females_NNS per_IN strain_NN )_) were_VBD measured_VBN with_IN a_DT
          tail-cuff_JJ system_NN as_IN reported_VBN [_NN 78_CD ]_NN ,_, except_IN that_DT 5_CD days_NNS
          of_IN training_NN were_VBD used_VBN ._. The_DT mice_NNS were_VBD analyzed_VBN in_IN the_DT same_JJ
          procedure_NN room_NN as_IN was_VBD used_VBN for_IN IOP_NNP measurment_NN ._.
        
        
          Clinical_NNP examinations_NNS
          For_IN most_JJS strains_NNS ,_, anterior_NN chambers_NNS were_VBD examined_VBN with_IN
          a_DT slit_NN lamp_NN biomicroscope_NN [_NN 16_CD ]_NN ._. At_IN least_JJS 8_CD mice_NNS of_IN
          each_DT strain_NN shown_VBN in_IN figure_NN 1_CD were_VBD evaluated_VBN ._. However_RB ,_, the_DT
          anterior_NN chambers_NNS of_IN C_NNP 57_CD BLKS_NNP /_NN J_NNP mice_NNS were_VBD only_RB evaluated_VBN
          under_IN a_DT dissection_NN microscope_NN at_IN the_DT time_NN of_IN IOP_NNP
          measurement_NN ._.
        
        
          Histological_NNP analysis_NN
          Eyes_NNS from_IN at_IN least_JJS 2_CD mice_NNS of_IN the_DT listed_VBN strains_NNS were_VBD
          fixed_VBN (_( 4_CD %_NN paraformaldehyde_NN or_CC Fekete_NNP 's_POS
          acid-alcohol-formalin_JJ fixative_JJ )_) processed_VBN ,_, paraffin_NN
          embedded_VBN and_CC sectioned_JJ as_IN previously_RB reported_VBD [_NN 15_CD 79_CD ]_NN ,_,
          except_IN that_IN the_DT paraformaldehyde_NN was_VBD buffered_JJ with_IN 0_CD ._. 1_CD M_NNP
          phosphate_NN buffer_NN ._. All_DT strains_NNS other_JJ than_IN CBA_NNP /_NN CaHN_NNP and_CC
          C_NNP 57_CD BLKS_NNP /_NN J_NNP strains_NNS were_VBD evaluated_VBN ._. The_DT eyes_NNS of_IN CBA_NNP /_NN CaJ_NNP and_CC
          BALB_NNP /_NN cJ_NN mice_NNS were_VBD also_RB fixed_VBN and_CC processed_VBN for_IN plastic_NN
          embedding_VBG (_( Historesin_NNP ,_, Leica_NNP ,_, Heidelberg_NNP ,_, Germany_NNP )_) ,_, and_CC
          sectioned_JJ as_IN previously_RB reported_VBD [_NN 14_CD 79_CD ]_NN ._. Saggital_NNP
          sections_NNS including_VBG the_DT pupil_NN and_CC optic_JJ nerve_NN were_VBD
          collected_VBN and_CC analyzed_VBN as_IN they_PRP contain_VBP most_JJS ocular_NN
          structures_NNS ._.
        
        
          Analysis_NNP of_IN Myoc_NNP
          Exons_NNP and_CC the_DT proximal_NN promoter_NN of_IN the_DT mouse_NN 
          Myoc_NNP gene_NN were_VBD amplified_VBN from_IN mouse_NN
          genomic_JJ DNA_NNP using_VBG the_DT following_NN combinations_NNS of_IN
          primers_NNS :_:
          Exon_NNP 1_CD :_: 5_CD '_POS -_: cttgcaggagaactttccagaa-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: atctcgaaggagattgttatagg-_NN 3_CD '_''
          5_LS '_POS -_: gaccagctggagacccaaaccag-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: gctcagatccactgacctaaa-_NN 3_CD '_''
          Exon_NNP 2_CD :_: 5_CD '_POS -_: tgaagccatactttaccaaccat-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: caaaagggagaagtctaacttc-_NN 3_CD '_''
          Exon_NNP 3_CD :_: 5_CD '_POS -_: agtcaaggctcacagagctaa-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: aagagtagctgctcaccgtgtacaag-_NN 3_CD '_''
          5_LS '_POS -_: agacattgacttagctgtggat-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: cggaacttcaccttttctggc-_NN 3_CD '_''
          Promoter_NNP :_: 5_CD '_POS -_: taggagaagtctcattatactgc-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: ttcactggaccagcataagga-_NN 3_CD '_''
          5_LS '_POS -_: tctgaggatgttcacaggtttat-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: tcttctggaaagttctcctgca-_NN 3_CD '_''
          Samples_NNP underwent_VBD 30_CD cycles_NNS of_IN amplification_NN with_IN
          Perkin-_NNP Elmer_NNP Taq_NNP polymerase_NN in_IN a_DT PTC_NNP Thermal_JJ Cycler_NNP (_( MJ_NNP
          Research_NNP ,_, MA_NNP )_) (_( 94_CD °_NN for_IN 40_CD sec_NN ,_, 57_CD °_NN for_IN 1_CD min_NN ,_, 72_CD °_NN for_IN 2_CD
          min_NN )_) ._. The_DT PCR_NNP products_NNS we_PRP purified_JJ and_CC sequenced_JJ as_IN
          described_VBN [_NN 22_CD ]_NN ._.
        
      
      
        Abbreviations_NNP
        Intraocular_NNP pressure_NN (_( IOP_NNP )_) ,_, C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP (_( B_NNP 6_CD )_) ,_, chromosome_NN
        (_( Chr_NNP )_) ,_, polymerase_NN chain_NN reaction_NN (_( PCR_NNP )_) ,_, carbonic_JJ anhydrase_NN
        (_( CA_NNP )_)
      
    
  
